Dr. Martina Schuessler-Lenz graduated from medical school at Mainz University Hospital, Germany. She worked as clinician-scientist in Berlin, New York and Barcelona and completed her fellowship in Internal Medicine, Hematology/Medical Oncology at the Mainz University Hospital (Professor Ch. Huber). She joined the pharmaceutical industry in 1992 and was responsible for several clinical drug development projects of anticancer agents. 

Since 2005 she is working as M.D. at the Paul-Ehrlich Institute in the Department Haematology, Cell and Gene Therapy, where she reviews Advanced Therapies in clinical trials and marketing authorizations, and provides advice to ATMP development and life cycle management. She is committed to facilitate the development of Advanced Therapies and has a specific focus in providing guidance to academic developers of ATMPs. 

Dr Martina Schüßler-Lenz has served as the elected Chair of the Committee for Advanced Therapies (CAT) of the European Medicines Agency's (EMA) since her appointment by the Paul-Ehrlich-Institut in February 2017. In accordance with the requirements of the European Commission, her mandate ended in February 2023 after two terms.